Mycoster (Ciclopirox Olamine)

Ciclopirox olamine exerts its antifungal effect by chelating essential metal ions within fungal cells, which blocks enzymes needed for sterol (ergosterol) synthesis and disrupts membrane transport proteins. This dual action compromises the fungal cell membrane, leading to loss of integrity and cell death.

The dosing regimen for Mycoster is determined by the prescribing healthcare professional based on the type and severity of the infection. Typically, a thin layer is applied to the affected area once or twice daily for the period recommended by the clinician. Patients should follow the specific instructions on the product label.

Safety data for ciclopirox olamine in pregnancy and lactation are limited, and the product is classified as pregnancy category unknown. Healthcare providers should weigh the potential benefits against possible risks before prescribing Mycoster to pregnant or nursing individuals, and it should only be used if deemed necessary.

To place an order, submit an enquiry on the Mycoster product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Compared with azole or allylamine topical antifungals, ciclopirox olamine has a distinct mechanism that does not rely on inhibiting lanosterol 14α‑demethylase. This can be advantageous in cases of azole‑resistant organisms. Mycoster is generally well tolerated, but like other topical agents it may cause local irritation; efficacy is comparable for common dermatophyte infections.

Mycoster should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and direct sunlight. Keep the container tightly closed when not in use and out of reach of children. Do not freeze or expose the product to extreme temperatures, as this may affect its stability.

The product is applied topically to clean, dry skin. A thin layer should be spread over the affected area and the surrounding margin, usually once or twice daily as directed by a healthcare professional. Hands should be washed after application, and the treated skin should be allowed to dry before covering with clothing or bandages.

Although rare, serious adverse reactions can include allergic contact dermatitis, severe skin rash, swelling, blistering, urticaria, or anaphylaxis. If any of these symptoms develop, the product should be discontinued immediately and medical attention sought. Patients should also monitor for worsening irritation and report any unexpected changes to their clinician.

Mycoster should not be used on broken or inflamed skin, on the eyes, mucous membranes, or on individuals with a known hypersensitivity to ciclopirox olamine or any excipients in the formulation. Persons with severe uncontrolled skin conditions should consult a physician before use. Pregnant or breastfeeding women should only use it if the benefits outweigh potential risks.